Medications

Living review compares treatments for atopic dermatitis

Abrocitinib, 200 mg daily, and upadacitinib, 30 mg daily, seem to be slightly better than dupilumab for atopic dermatitis, according to a living review published online March 16 in JAMA Dermatology.

Inflammatory disorders

Patients with inflammatory skin diseases have high stress scores

About two-thirds of patients with inflammatory skin diseases have high reported stress scores, according to a letter to the editor published online Feb. 19 in the Journal of the European Academy of Dermatology and Venereology.

Diseases, Conditions, Syndromes

New insight into how atopic dermatitis develops

Atopic dermatitis, a common skin condition affecting both children and adults, is often thought of as an inflammatory disease that arises from a breakdown in the barrier function of the skin. Now a new study pinpoints a cascade ...

Diseases, Conditions, Syndromes

FDA approves Rinvoq for treatment of atopic dermatitis

The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.

Diseases, Conditions, Syndromes

COVID-19 severity does not differ for patients with skin conditions

For patients with psoriasis, vitiligo, atopic dermatitis (AD), and chronic urticaria (CU), COVID-19 severity does not differ, but treatment of COVID-19 may affect the course of skin disease, according to a letter to the editor ...

Immunology

Suffering from psoriasis? Blame this trio of proteins

About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed skin and painful, scaly rashes. Although there are effective treatments for psoriasis, not everyone responds ...

Genetics

Gene for sex hormone synthesis could play key role in eczema

A study led by UT Southwestern dermatologists suggests that a common inflammatory skin condition may stem from poorly regulated sex hormones. The finding, published this week in PNAS, could offer an unexpected new target ...

page 9 from 25